Jiangsu Hualan New Pharmaceutical Material Co., Ltd. (301093.SZ) Latest Company News

Sep 29, 2026, 08:15 UTC
Jiangyin Hualan Electromechanical Technology, controlling shareholder of Hualan Shares, pledged 2.21 million company shares to Agricultural Bank of China Jiangyin Branch for its own production and operations.
Sep 24, 2026, 07:46 UTC
Jiangyin Hualan Electromechanical Technology, controlling shareholder of Hualan Co., released a pledge on 2.21 million shares of the company on September 23, 2026.
Source:
- finance.sina.cn
Sep 23, 2026, 12:00 UTC
Rui Zhong Life Insurance's own funds, holder of 16.41% of Hualan Co., plans to reduce its stake by up to 3.00% of total shares between October 23, 2026 and January 22, 2027.
Source:
- finance.sina.cn
Sep 21, 2026, 07:57 UTC
Hualan Co., Ltd. received a registration acceptance notice from the National Association of Financial Market Institutional Investors for its planned issuance of up to RMB 1 billion in science and technology innovation bonds (medium-term notes).
Source:
- finance.sina.cn
Jul 27, 2026, 10:18 UTC
Hualan Stock formulates the Information Disclosure Affairs Management System for Debt Financing Instruments in the Interbank Bond Market.
Source:
- finance.sina.cn
Jul 27, 2026, 10:18 UTC
Hualan Stock adjusts its wholly-owned subsidiary Hainan Lingqing Digital Pharmaceutical Technology Co., Ltd.'s investment in Wuxi Natural Constant Technology Co., Ltd.
Source:
- finance.sina.cn
Jul 27, 2026, 10:18 UTC
Hualan Stock plans to change its registered capital and amend its articles of association due to the completion of share buyback cancellation in 2025.
Source:
- finance.sina.cn

301093.SZ

Jiangyin Hualan Electromechanical Technology, controlling shareholder of Hualan Shares, pledged 2.21 million company shares to Agricultural Bank of China Jiangyin Branch for its own production and operations.

Jiangyin Hualan Electromechanical Technology, controlling shareholder of Hualan Co., released a pledge on 2.21 million shares of the company on September 23, 2026.

Rui Zhong Life Insurance's own funds, holder of 16.41% of Hualan Co., plans to reduce its stake by up to 3.00% of total shares between October 23, 2026 and January 22, 2027.

Hualan Co., Ltd. received a registration acceptance notice from the National Association of Financial Market Institutional Investors for its planned issuance of up to RMB 1 billion in science and technology innovation bonds (medium-term notes).

Hualan Stock formulates the Information Disclosure Affairs Management System for Debt Financing Instruments in the Interbank Bond Market.

Hualan Stock adjusts its wholly-owned subsidiary Hainan Lingqing Digital Pharmaceutical Technology Co., Ltd.'s investment in Wuxi Natural Constant Technology Co., Ltd.

Hualan Stock plans to change its registered capital and amend its articles of association due to the completion of share buyback cancellation in 2025.